References in periodicals archive ?
Shares of the Company's common stock commenced trading on the Nasdaq Capital Market under the ticker symbol 'NBSE' as of market open on July 15, 2019.
(Nasdaq: NBSE) ('NeuBase' and the 'Company'), a biotechnology company developing next generation antisense therapies to address genetic diseases, announced today that its chairman and chief executive officer, Dietrich A.
* NeuBase Therapeutics, Inc.(NASDAQ: NBSE) gained 12.9% to close at $5.08.
Upon closing of the transaction, the combined company will change its name to NeuBase Therapeutics and the trading symbol will become "NBSE".
The inaugural conference, Natural Beauty Summit Europe (NBSE), will take place on Nov.
In " Carnegie Mellon University Is a Big Backer of This Biotech Stock," Ed Lin examines why this private research university has disclosed that it owns more than 5% of Neubase Therapeutics Inc (NASDAQ: NBSE).
Acronyms browser ?
Full browser ?
- NBSP code